Clinical Trial Detail

NCT ID NCT03150693
Title Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Alliance for Clinical Trials in Oncology
Indications

acute lymphocytic leukemia

Therapies

Rituximab

Doxorubicin

Mercaptopurine

Methotrexate

Cyclophosphamide + Cytarabine

Thioguanine

Allopurinol

Daunorubicin

Dexamethasone

Vincristine

inotuzumab ozogamicin

Age Groups: adult

Additional content available in CKB BOOST